400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
2025-05-27
新型生物制剂研发商
医药研发/制造
化学&生物药
诺和诺德;
诺和诺德;
Catalio Capital Management;
Catalio Capital Management;
LifeArc Ventures;
Qatar Investment Authority;
Sofinnova Partners;
5AM Ventures;
Roche Ventures;
百时美施贵宝;
Agent Capital;
MP Healthcare Venture Management;
Sixty Degree Capital
动脉网-最新2026-06-10
求实药社2026-06-10
中国经营报2026-06-10
功能与专用化学品2026-06-10
中国医药报2026-06-10
动脉网-最新2026-06-10
中国农业科学院2026-06-10
药融圈info2026-06-10
精准药物2026-06-10
医药观澜2026-06-10